Trials / Completed
CompletedNCT02351934
Early Diuresis Following Colorectal Surgery
A Prospective, Randomized Study Evaluating the Efficacy and Safety of Early Diuresis Following Colorectal Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out if giving a medicine called furosemide, which is a diuretic or water pill, after colon surgery will safely shorten the patient's length of hospital stay.
Detailed description
This study will assess if administration of a loop diuretic, specifically furosemide, to achieve euvolemia can safely reduce length of stay following colorectal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Furosemide | |
| DRUG | Celecoxib | Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain or inflammation. |
| DRUG | Gabapentin | Gabapentin is a oral drug used to treat seizures, postherpetic neuralgia, and restless legs syndrome. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2015-01-30
- Last updated
- 2018-05-07
- Results posted
- 2017-06-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02351934. Inclusion in this directory is not an endorsement.